Results

Total Results: 1,541 records

Showing results for "months".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_disposition-comments.pdf
    September 01, 2011 - responses to the comments are posted for public viewing on the EHC Program Web site approximately 3 months … flare during the double-blind component of the study and who were reintroduced to etanercept up to 4 months … For balance, Amgen recommends that the following sentence be added: “After 12 months of treatment, … be added: “Of the 10 patients enrolled in the etanercept arm of the trial, 1 failed to complete 12 months … Of the 14 patients enrolled in the infliximab arm, 5 patients failed to complete 12 months – 4 because
  2. effectivehealthcare.ahrq.gov/sites/default/files/data-points_1_diabetic-foot-ulcers_data_02-2011.pdf
    January 01, 2011 - Fee-for-Service Cohort Population (Millions), 2007 Algorithm Period of Continuous Enrollment (Months
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/bimp-protocol.pdf
    September 27, 2022 - The disposition of comments for systematic reviews and technical briefs will be published 3 months after
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/bereaved-persons-protocol.pdf
    June 01, 2023 - individuals develop complicated grief or grief with a high level of distress that extends 6 to 12 months … Timing: predeath, acute, or 6-12 months post loss, and more than 1 year post loss? b. … Timing: predeath, acute, or 6-12 months post loss, and more than 1 year post loss? b. … Regarding timing, we will differentiate predeath, acute, or 6-12 months post loss, and more than 1 year … Resilience to loss and chronic grief: a prospective study from preloss to 18-months postloss.
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-adult-treatment-update_research-protocol.pdf
    December 31, 2017 - for PTSD within 1 month of trauma exposure, and 17.0 percent continue to meet criteria for PTSD 12 months … defined by evidence-based guidelines as receiving either appropriate pharmacotherapy for 2 or more months … Psychodynamic therapy for PTSD would consist of weekly to biweekly sessions over a period of several months … The disposition of comments for systematic reviews and technical briefs will be published 3 months after
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_research-protocol.pdf
    March 22, 2016 - We will require at least six months of treatment. … Final health  or patient-­ centered  outcomes: Incident MCI or  AD Timing Minimum followup  of 6   months … for intermediate   outcomes Minimum followup  of 6   months for intermediate   outcomes None Settings … Alzheimer’s disease, and  incident MCI or Alzheimer’s disease Timing For KQ1-­2:  Minimum followup  of 6  months … The disposition of comments for systematic reviews and technical briefs will be published three months
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypothyroidism-hyperthyroidism-screening-treatment_disposition-comments.pdf
    February 01, 2012 - responses to the comments are posted for public viewing on the EHC Program Web site approximately 3 months … consistent with experience--we all know people or patients who in retrospect were symptomatic for months … duration to dosage column header; on the Nagasaki study I'm unclear whether you are saying that after 5 months … or whether the duration was 5 months for the whole study and the dose wasn't stated We have added … as the two studies cited are problematic (one did not require subclinical disease for at least 3 months
  8. effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - depending on expert comments received on interventions issued for comment during the preceding 6 months … patients with moderate renal impairment), and had a history of at least 2 gout flares in the prior 12 months … proportion of patients receiving lesinurad achieved the sUA-level goal of less than 6.0 mg/dL at 6 months
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonpharma-treatment-pain_research-protocol-amended.pdf
    September 20, 2017 - 5: Primary chronic tension headache (defined as 15 or more headache days per month for at least 3 months … • Timing: o Duration of followup: short term (up to 6 months), intermediate term (6-12 months) … ), intermediate term (6-12 months) and long term (at least 1 year); focus on longer term (>1 year) … Trials lasting ≥ 6 months which include a supervised intervention followed by continued home treatment … The disposition of comments for systematic reviews and technical briefs will be published three months
  10. Arcia-notes-Teresa (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/arcia-presentation.pdf
    May 29, 2025 - Arcia-notes-Teresa First, I'd like to acknowledge my colleagues, Dr. Sue Bakken is my mentor and   is the PI of one of the major projects I'll be talking about today. 1 And  here you  can  also see our funding sources. 2 Today I'm going to talk about some of the opportunities that technology crea…
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-provider-adherence_executive.pdf
    May 01, 2013 - increase in the change of percentage of patients treated with inhaled steroid from baseline to 12 months … ranging from 52 percent to 104 percent; change in prescribing over time (52 percent change over 6 months … and GP guidelines over a long period (1990–2007), inconsistent followup periods ranging from 3-12 months … : 81 percent) or hospitalizations (baseline: 96 percent, 6 months: 94 percent) was reported in the … : baseline: 49 percent; 6 months: 38 percent).
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
    December 31, 2013 - 12 months Glycemic control, insulin resistance, and beta-cell function variables Decrease … Exenatide + metformin were superior to placebo + metformin in reducing HbA1c at 12 months (P < 0.05 … Significant decrease of waist circumference, and hip circumference after 12 months (P < 0.01, and P … Glycemic control Improvement of HbA1c and PPG at 6 ( p < 0.05), 9 ( p < 0.01) and 12 months ( … A Similar decrease of body weight and BMI was observed with both treatments at 12 months ( p < 0.05
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/dental-post-transplant-complications-rapid-research.pdf
    May 01, 2025 - as 55% of solid organ transplant recipients experiencing at least one infection within the first 12 months … Patients in the treatment group used the oral mucosal protectant twice daily for three months. … Only emergency dental care should be performed at least 3 months after transplant and when organ rejection … In fact, some guidelines suggest avoiding any dental treatment for at least three months post- transplant … of Oral Oncology KQ Key Question MASCC Multinational Association of Supportive Care in Cancer mo Months
  14. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/telehealth-during-COVID-19-amendments.pdf
    April 28, 2022 - How do the characteristics of patients, providers, and health systems differ between the first four months … the characteristics of telehealth use in the first 9 four months … of COVID-19 (March 2020 through July 2020) with telehealth use after the first four months. … April 2022 PICOTS: Timing All KQ: the era of COVID-19 (March 2020-present) KQ1d: During the first 4 months … The disposition of comments for systematic reviews and technical briefs will be published 3 months after
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ped-mindfulness-protocol-amendment.pdf
    February 05, 2025 - which we will aggregate into the following intervals: 4 to <8 weeks, 8 to <12 weeks, 12 weeks to <6 months … , 6 months to <12 months, and ≥12 months since the beginning of the intervention or baseline assessment … The disposition of comments for systematic reviews and technical briefs will be published 3 months after
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ped-mindfulness-protocol-amended.pdf
    September 25, 2024 - which we will aggregate into the following intervals: 4 to <8 weeks, 8 to <12 weeks, 12 weeks to <6 months … , 6 months to <12 months, and ≥12 months since the beginning of the intervention or baseline assessment … The disposition of comments for systematic reviews and technical briefs will be published 3 months after
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_consumer.pdf
    November 01, 2016 - How often and for how many months would I need to meet with the trained provider?
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-208-bipolar-adults-disposition-comments.pdf
    August 07, 2018 - that alleviate depression may cause mania, hypomania, or rapid cycling (four or more episodes in 12 months … decision to limit inclusion of studies examining bipolar depression treatments to a minimum of 3 months … having a minimum duration that allows for at least full remission (e.g., DSM-5 defines it as two months … endures for a full 3 month followup period and thus does not require retreatment in less than 3 months … The authors’ decision to exclude depression trials of less than 3 months duration is, as best I can
  19. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/rotator-cuff-tear_executive.pdf
    July 01, 2010 - The majority of patients first undergo 6 weeks to 3 months of nonoperative treatment, which may consist … cuff integrity, pain, range of motion, and/or strength) and have a minimum followup duration of 12 months … of several years are needed; at the very least, studies should follow patients for a minimum of 12 months
  20. Obesity (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_june_2012.pdf
    January 01, 2012 - depending on expert comments received on interventions issued for comment during the preceding 6 months … norepinephrine-releasing drug that was approved by FDA in 1959 as an appetite suppressant for short-term (3 months … with a decision date set for April 17, 2012. 8 In April 2012, FDA extended the decision date three months … Administration for inclusion in its therapeutic goods registry for treating T2DM and obesity for up to 12 months … implantation, a mean excess weight loss of 29.8%, reduction of HbA1c from 8.4% at baseline to 7.0% after 6 months

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: